 Home > Active Ingredient News > Drugs Articles > Up to $225 million: Eli Lilly and Telix Pharmaceuticals reach licensing deal for olaratumab

Up to $225 million: Eli Lilly and Telix Pharmaceuticals reach licensing deal for olaratumab

 Last Update: 2022-06-15
 Source: Internet
 Author: User

Tags

types immune response

insulin growth factor 1

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On April 10, 2022, Telix Pharmaceuticals announced a licensing agreement with Eli Lilly

Olaratumab was originally developed by Eli Lilly as a (non-radiolabeled) monoclonal antibody targeting platelet-derived growth factor receptor alpha (PDGFRα) and was approved by the FDA in October 2016 for the treatment of adult soft tissue sarcoma (STS)

Approved drugs targeting PDGFRα

STS is a malignant tumor originating from adipose, fascia, muscle, fiber and other tissues.

Standard treatments for STS include surgery, radiation therapy, and/or chemotherapy, and for patients with advanced, unresectable, or metastatic disease, treatment typically includes chemotherapy with a single agent (eg, doxorubicin) or an anthracycline-based combination regimen

Telix is a late-stage biopharmaceutical company headquartered in Melbourne, Australia, with international operations in Belgium, Japan, Switzerland and the United States

Original in English: https://telixpharma.

https://telixpharma.
com/news-media/telix-announces-licence-agreement-with-lilly-for-olaratumab/

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

N-Methyl-L-alanine3913-67-5

CAS No.: 3913-67-5

Industrial Grade

$1-1.04/KG FOB

High Purity 99% PEG MGF CAS 108174-48-7 Customized Peptides from China OUDA

CAS No.: 108174-48-7

Pharmacy Grade

$2-2.6/G FOB

Wholesales Purity 99 Peptides Powder Sema Tirz Retatrutide 5mg/10mg/15mg to Door From China

CAS No.: 2023788-19-2

Pharmacy Grade

$150-180/KG FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.